These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 26056354)
1. Influence of glycosylation on diagnostic and prognostic accuracy of N-terminal pro-B-type natriuretic peptide in acute dyspnea: data from the Akershus Cardiac Examination 2 Study. Røsjø H; Dahl MB; Jørgensen M; Røysland R; Brynildsen J; Cataliotti A; Christensen G; Høiseth AD; Hagve TA; Omland T Clin Chem; 2015 Aug; 61(8):1087-97. PubMed ID: 26056354 [TBL] [Abstract][Full Text] [Related]
2. Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department. Gaggin HK; Chen-Tournoux AA; Christenson RH; Doros G; Hollander JE; Levy PD; Nagurney JT; Nowak RM; Pang PS; Patel D; Peacock WF; Walters EL; Januzzi JL; Am Heart J; 2017 Oct; 192():26-37. PubMed ID: 28938961 [TBL] [Abstract][Full Text] [Related]
3. Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study. Pervez MO; Winther JA; Brynildsen J; Strand H; Christensen G; Høiseth AD; Myhre PL; Røysland R; Lyngbakken MN; Omland T; Røsjø H Biomarkers; 2018 Nov; 23(7):654-663. PubMed ID: 29733687 [TBL] [Abstract][Full Text] [Related]
4. Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality. deFilippi CR; Seliger SL; Maynard S; Christenson RH Clin Chem; 2007 Aug; 53(8):1511-9. PubMed ID: 17586595 [TBL] [Abstract][Full Text] [Related]
5. Mid-regional pro-adrenomedullin in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 Study. Pervez MO; Lyngbakken MN; Myhre PL; Brynildsen J; Langsjøen EC; Høiseth AD; Christensen G; Omland T; Røsjø H Clin Biochem; 2017 May; 50(7-8):394-400. PubMed ID: 28065681 [TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 23 in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 Study. Lyngbakken MN; Pervez MO; Brynildsen J; Pedersen MH; Sølvernes J; Christensen G; Høiseth AD; Omland T; Røsjø H Clin Biochem; 2018 Feb; 52():41-47. PubMed ID: 29074091 [TBL] [Abstract][Full Text] [Related]
7. Combination of quantitative capnometry, N-terminal pro-brain natriuretic peptide, and clinical assessment in differentiating acute heart failure from pulmonary disease as cause of acute dyspnea in pre-hospital emergency setting: study of diagnostic accuracy. Klemen P; Golub M; Grmec S Croat Med J; 2009 Apr; 50(2):133-42. PubMed ID: 19399946 [TBL] [Abstract][Full Text] [Related]
8. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Morello A; Lloyd-Jones DM; Chae CU; van Kimmenade RR; Chen AC; Baggish AL; O'Donoghue M; Lee-Lewandrowski E; Januzzi JL Am Heart J; 2007 Jan; 153(1):90-7. PubMed ID: 17174644 [TBL] [Abstract][Full Text] [Related]
9. Cardiac Troponin T and NT-proBNP for Prediction of 30-Day Readmission or Death in Patients with Acute Dyspnea: Data from the Akershus Cardiac Examination 2 Study. Bhatnagar R; Berge K; Røysland R; Høiseth AD; Brynildsen J; Christensen G; Omland T; Røsjø H; Lyngbakken MN Cardiology; 2023; 148(6):506-516. PubMed ID: 37544298 [TBL] [Abstract][Full Text] [Related]
10. Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea. Bayes-Genis A; Lloyd-Jones DM; van Kimmenade RR; Lainchbury JG; Richards AM; Ordoñez-Llanos J; Santaló M; Pinto YM; Januzzi JL Arch Intern Med; 2007 Feb; 167(4):400-7. PubMed ID: 17325303 [TBL] [Abstract][Full Text] [Related]
11. Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure. Baggish AL; van Kimmenade RR; Januzzi JL Am J Cardiol; 2008 Feb; 101(3A):49-55. PubMed ID: 18243859 [TBL] [Abstract][Full Text] [Related]
12. N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study. Januzzi JL; Chen-Tournoux AA; Christenson RH; Doros G; Hollander JE; Levy PD; Nagurney JT; Nowak RM; Pang PS; Patel D; Peacock WF; Rivers EJ; Walters EL; Gaggin HK; J Am Coll Cardiol; 2018 Mar; 71(11):1191-1200. PubMed ID: 29544601 [TBL] [Abstract][Full Text] [Related]
13. Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP. Gegenhuber A; Struck J; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T Clin Chem; 2006 May; 52(5):827-31. PubMed ID: 16543387 [TBL] [Abstract][Full Text] [Related]
14. ProBNP That Is Not Glycosylated at Threonine 71 Is Decreased with Obesity in Patients with Heart Failure. Lewis LK; Raudsepp SD; Prickett TCR; Yandle TG; Doughty RN; Frampton CM; Pemberton CJ; Richards AM Clin Chem; 2019 Sep; 65(9):1115-1124. PubMed ID: 31092393 [TBL] [Abstract][Full Text] [Related]
15. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563 [TBL] [Abstract][Full Text] [Related]
16. Neither race nor gender influences the usefulness of amino-terminal pro-brain natriuretic peptide testing in dyspneic subjects: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. Krauser DG; Chen AA; Tung R; Anwaruddin S; Baggish AL; Januzzi JL J Card Fail; 2006 Aug; 12(6):452-7. PubMed ID: 16911912 [TBL] [Abstract][Full Text] [Related]
17. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea. Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868 [TBL] [Abstract][Full Text] [Related]
18. Impact of increased body mass index on accuracy of B-type natriuretic peptide (BNP) and N-terminal proBNP for diagnosis of decompensated heart failure and prediction of all-cause mortality. Christenson RH; Azzazy HM; Duh SH; Maynard S; Seliger SL; Defilippi CR Clin Chem; 2010 Apr; 56(4):633-41. PubMed ID: 20167699 [TBL] [Abstract][Full Text] [Related]
19. Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department. Januzzi JL; Sakhuja R; O'donoghue M; Baggish AL; Anwaruddin S; Chae CU; Cameron R; Krauser DG; Tung R; Camargo CA; Lloyd-Jones DM Arch Intern Med; 2006 Feb; 166(3):315-20. PubMed ID: 16476871 [TBL] [Abstract][Full Text] [Related]
20. Lack of diagnostic and prognostic utility of circulating plasma myeloperoxidase concentrations in patients presenting with dyspnea. Shah KB; Kop WJ; Christenson RH; Diercks DB; Kuo D; Henderson S; Hanson K; Mehra MR; deFilippi CR Clin Chem; 2009 Jan; 55(1):59-67. PubMed ID: 18988754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]